<DOC>
	<DOCNO>NCT00225251</DOCNO>
	<brief_summary>This ten-week , double-blind study Wellbutrin XL outpatient dysthymic disorder , form low-grade chronic depression . We hypothesize patient take Wellbutrin XL show great improvement depression symptom psychosocial functioning patient take placebo .</brief_summary>
	<brief_title>Wellbutrin XL Dysthymic Disorder</brief_title>
	<detailed_description>This ten-week , double-blind , placebo-controlled study design evaluate tolerability , dose efficacy Wellbutrin XL outpatients meet Diagnostic Statistical Manual-IV criterion early onset , primary type dysthymic disorder ( low-grade chronic depression ) . It hypothesize patient take Wellbutrin XL show great improvement depression symptom psychosocial functioning patient take placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Dysthymic Disorder</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Male female outpatient 1865 year age . Patients Diagnostic Statistical Manual Fourth Edition ( DSMIV ) diagnosis dysthymic disorder , early onset . Patients total score 12 high Hamilton Depression Scale ( 24 item ) baseline . Patients DSMIV diagnosis Delirium , Dementia , Amnestic , Cognitive Disorders . Patients pregnant nursing woman . Patients principal diagnosis meeting DSMIV criterion : Major Depressive disorder , Bipolar Disorder cyclothymia , Schizophrenia , Delusional ( Paranoid ) Disorders Psychotic Disorders elsewhere classify , Severe Borderline Personality Disorder Patients current prior diagnosis Anorexia Nervosa Bulimia Patients , within past 6 month , meet DSMIV criterion abuse dependence drug , include alcohol . Patients would pose serious risk suicide course study , evidence one following : Report specific plan killing , A score 3 high Hamilton Depression Rating Scale item # 3 rat treat clinician Week 0 , ( indicative active suicidal thought behavior ) , A suicide attempt within past 12 month require emergency room visit , medical psychiatric hospitalization , otherwise deem lifethreatening ( e.g . overdose &gt; 1 week 's dose medication ) . Patients history recurrent Grand Mal seizures risk Grand Mal seizure , medical condition Wellbutrin XL would contraindicate , include history head trauma . Use psychotropic medication within 1 week start study medication Use monoamine oxidase inhibitor ( type antidepressant ) ( MAOI ) within 14 day prior initial dose study medication . Use fluoxetine within 28 day initial dose study medication . Use ZybanÂ® form bupropion hydrochloride ( i.e . Wellbutrin immediate release Wellbutrin Sustained Release ( SR ) ) within 2 week initial dose medication . Patients fail respond adequate trial ( minimum six consecutive week ) two different class antidepressant medication ( see Table 1 definition adequate trial . ) Patients unstable medical condition , acute hyperthyroidism , uncorrected hypothyroidism , undiagnosed fever , uncontrolled angina , serious medical illness , include cardiovascular , hepatic , respiratory , hematological , endocrinologic neurologic disease , clinically significant laboratory abnormality . Patients begin course psychotherapy within 3 month start study , plan terminate ongoing psychotherapy prior end study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Dysthymic Disorder</keyword>
	<keyword>Dysthymia</keyword>
	<keyword>Depression</keyword>
	<keyword>Chronic Depression</keyword>
	<keyword>Wellbutrin XL</keyword>
</DOC>